ISOTOPE‑DRIVEN SEMI × NUCLEAR CROSSOVER – ASPI AS DUAL‑RAIL OPTION
4/21/26
SEQH CAPITAL RESEARCH – TEAR SHEET
ISOTOPE‑DRIVEN SEMI × NUCLEAR CROSSOVER – ASPI AS DUAL‑RAIL PLAY
WHAT THIS REPORT ANSWERS
The report argues that ASP Isotopes (ASPI) is the first listed pure‑play on the “isotope‑compute crossover”: the same hyperscalers that are signing multi‑GW nuclear PPAs and funding grid upgrades are also the natural buyers of isotopically enriched Si‑28for quantum and high‑end AI substrates.
It introduces the SEQH Isotope‑Compute Score (ICS) to rank equities by simultaneous exposure to Si‑28 and nuclear fuel/Haleu demand, and concludes that ASPI (ICS 84) screens as the highest‑conviction dual‑exposure name, ahead of LEU (67), BWXT (62), and NNE (58).
POLICY, CAPEX, AND NUCLEAR BACKDROP
Big‑5 hyperscaler capex guidance for 2026 totals roughly $660–690B, up about 70% versus 2025, with Microsoft explicitly pointing to an $80B Azure backlog constrained by power, not chip supply, making nuclear baseload a strategic constraint.
SEQH’s Nuclear Infrastructure Databook tracks 71 corporate nuclear deals, with ~13+ GWof contracted nuclear capacity already in Amazon/Google/Meta/Microsoft hands and >20 GW including options.
The White House Ratepayer Protection Pledge (Mar 4, 2026) hard‑codes that seven AI players (AMZN, GOOG, META, MSFT, OpenAI, ORCL, xAI) will fund their own generation and grid upgrades, effectively forming a buy‑side cartel for nuclear‑heavy baseload; the same names form the core potential Si‑28 customer list.
The 2028 Russian uranium import ban removes ~44% of Western enrichment, raising the value of Western HALEU/LEU+ supply chains such as ASPI’s QLE subsidiary and LEU’s Piketon facility.
ASPI’S SI‑28 PLATFORM & DEMAND STACK
ASPI’s dedicated Si‑28 plant in Pretoria has demonstrated >80 kg/yr at 99.995% enrichment, with three signed 2Q26 contracts (major U.S. semi, global industrial gas company, large U.S. buyer); further Iceland and U.S. plants could lift capacity toward 150–250 kg/yr and 100–200 kg/yr respectively in the late‑decade window.
Early 2025 work benchmarks Si‑28 at ~$550k/kg with ~85% gross margins at current scale; SEQH models industrial pricing drifting into the $250–400k/kg range as volumes ramp, still supporting $100–200M+ Si‑28 revenue potential at ~200 kg/yr and forming a large chunk of ASPI’s $150–300M 2031 electronic‑gases EBITDA target.
Demand is decomposed into four pulls:
Silicon spin qubits (Intel, Diraq, SQC, Quantum Motion, Equal1, IMEC programs) needing 4N+ Si‑28 for decoherence suppression.
Thermal management in next‑gen AI accelerators where enriched Si‑28 substrates can boost thermal conductivity meaningfully at megawatt‑class rack densities.
Cryogenic CMOS control for spin‑qubit stacks at 1–4 K, where Si‑28 helps reduce noise.
Smaller PV/metrology uses that provide a baseline floor.
The key point: the Si‑28 buyer set is effectively identical to the nuclear PPA buyer set, hyperscalers that care about both MW‑scale baseload and watt‑per‑TOPS efficiency, making ASPI’s product “on both menus.”
ISOTOPE‑COMPUTE SCORE & CORRELATION RISK
The ICS combines five factors, Si‑28 capacity/contracts (30), HALEU/LEU+ optionality (20), hyperscaler proximity (20), AI‑capex torque (15), and balance sheet (15), to score dual‑exposure names on a 0–100 scale.
ASPI leads at 84, reflecting: three Si‑28 contracts, multi‑site expansion plans, QLE HALEU rail, direct hyperscaler adjacency, and a $333M cash pile; LEU (67) leads HALEU but lacks a compute leg; BWXT (62) and NNE (58) have strong nuclear but no isotope platform.
Once Si‑28 and QLE revenues switch on, SEQH expects ASPI’s forward revenue to correlate 0.6–0.8 with hyperscaler AI capex, versus ~0.2–0.4 for fuel‑only names, turning ASPI into a quasi‑index on nuclear‑accelerated AI infra that responds to both capex shocks and nuclear policy.
SEQH VIEW ON ASPI & CATALYSTS
SEQH reiterates its bullish ASPI thesis: January 2026 SOTP base case $14.79/share, probability‑weighted path to $18.09 (~+126%), and now a revised 18‑month expected return range of +150–175% as the Si‑28 compute leg compounds with QLE’s HALEU leg, with bull scenarios >+225%.
Key upside levers over the next 18 months include: first Si‑28 shipments (2Q26), Carbon‑14/Yb‑176 and helium ramps, QLE spin‑off progression and HALEU offtake, Iceland permitting, and the first named hyperscaler Si‑28 customer, which would shift perception from specialty isotope to strategic substrate.
WHAT PAID MEMBERS GET IN THE FULL REPORT
Upgrade to access the full Isotope‑Driven Semiconductor and Nuclear Crossover report, including:
A detailed link between hyperscaler AI capex, nuclear PPAs, and Si‑28 demand, plus a multi‑plant ASPI capacity and pricing model through 2031.
The full Isotope‑Compute Score panel and scenario work showing how capex shocks propagate into Si‑28 volumes, QLE HALEU economics, and ASPI’s 2031 revenue/EBITDA paths.
An 18‑month catalyst calendar around Si‑28 shipments, QLE milestones, and nuclear‑policy events that together define the re‑rating window for ASPI and peers.
CLICK FOR LINK TO Q2 PAID MEMBER PROMO (20% OFF FOR LIFE)
FULL ISOTOPE‑DRIVEN SEMI × NUCLEAR CROSSOVER – ASPI AS DUAL‑RAIL PLAY REPORT ATTACHED BELOW:
